EV/EBITDA spoločnosti 10x Genomics
Aká je hodnota metriky EV/EBITDA spoločnosti 10x Genomics?
Hodnota metriky EV/EBITDA spoločnosti 10x Genomics, Inc. je N/A
Aká je definícia metriky EV/EBITDA?
EV/EBITDA je podniková hodnota vydelená EBITDA (zisk pred odpočítaním úrokov, daní, odpisov, a amortizácie). Meria nákladnosť akcie a používa sa na porovnávanie spoločností medzi sebou častejšie ako P/E ratio. Meria cenu akú investor zaplatí za pohyb hotovosti v spoločnosti.
Price to earnings ratios are impacted by a company's choice of capital structure - companies which raise money via debt will have lower P/Es (and therefore look cheaper) than companies that raise an equivalent amount of money by issuing shares, even though the two companies might have equivalent enterprise values. A sample case is when a company with debt were to raise money by issuing shares of stock, and then used the money to pay off the debt, this company's P/E ratio would shoot up because of the increased number of shares - although nothing about the fundamental value of the business has changed. EV / EBITDA is unaffected by capital structure as enterprise value includes the value of debt, and EBITDA is available to all investors (debt and equity) as it excludes interest payments on that debt. It is ideal for analysts and potential investors looking to compare companies within the same industry.
EV/EBITDA spoločností v sektore Health Care sektor na NASDAQ v porovnaní so spoločnosťou 10x Genomics
Čomu sa venuje spoločnosť 10x Genomics?
10x Genomics, Inc., a life science technology company, develops and sells instruments, consumables, and software for analyzing biological systems in North America, Europe, the Middle East, Africa, China, and the Asia Pacific. The company provides chromium and chromium connect instruments, microfluidic chips, slides, reagents, and other consumables products. Its single cell solutions runs on its chromium instruments, which include single cell gene expression for measuring gene activity on a cell-by-cell basis; single cell immune profiling for measuring the activity of immune cells and their targets; single cell ATAC for measuring epigenetics comprising the physical organization of DNA; and single cell multiome ATAC + gene expression for measuring the genetic activity and epigenetic programming in the same cells across tens of thousands of cells in a single experiment. The company also provides visium spatial gene expression solution for measuring spatial gene expression patterns across a single tissue sample or gene expression and protein co-detection when combined with immunofluorescence. It serves various academic, government, biopharmaceutical, biotechnology, and other institutions. The company was formerly known as 10X Technologies, Inc. and changed its name to 10x Genomics, Inc. in November 2014. 10x Genomics, Inc. was incorporated in 2012 and is headquartered in Pleasanton, California.
Firmy s metrikou ev/ebitda podobnou spoločnosti 10x Genomics
- Hodnota metriky EV/EBITDA spoločnosti Bold Capital Enterprises je N/A
- Hodnota metriky EV/EBITDA spoločnosti Gabriel Resources je N/A
- Hodnota metriky EV/EBITDA spoločnosti GT Gold je N/A
- Hodnota metriky EV/EBITDA spoločnosti Allied Copper je N/A
- Hodnota metriky EV/EBITDA spoločnosti Dharani Sugars and Chemicals je N/A
- Hodnota metriky EV/EBITDA spoločnosti Cleantek Industries Inc je N/A
- Hodnota metriky EV/EBITDA spoločnosti 10x Genomics je N/A
- Hodnota metriky EV/EBITDA spoločnosti Rigel Pharmaceuticals je N/A
- Hodnota metriky EV/EBITDA spoločnosti Spark Power je N/A
- Hodnota metriky EV/EBITDA spoločnosti Syrah Resources je N/A
- Hodnota metriky EV/EBITDA spoločnosti The Motor & General Finance je N/A
- Hodnota metriky EV/EBITDA spoločnosti Bernard Krief Consultants SA je N/A
- Hodnota metriky EV/EBITDA spoločnosti Vimy Resources je N/A